Published mark
NANOVIRICIDES, INC.
NYSE: NNVC. Canonical company identity and public leadership record.
US
Record source reportedRecord not claimedNo Eval published
- Alpha ID
- alpha:company:6b088d6e-a8aa-47cb-9be3-eb19915ed477
- SEC CIK
- 0001379006
- Record version
- vpublic-1:ro-d751713988987e9331980363e24189ce, published Oct 22, 2026
- Newest evidence
- Oct 8, 2025
- Monitoring
- Not yet monitored Details
- Integrity
- Not yet signed Methodology
- CEO
- Anil DiwanPresident and Chief Executive Officer
- Chair
- Anil Diwan
- Independent
- Not published5 directors published
- Published claims
- 263 distinct sources
- Evidence records
- 50 pinned
- Source conflicts
- 0None open
Built from 3 distinct sources and 5 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.
CorroboratedSource reportedAlpha inferenceNot disclosed
Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works
DIRECTOR APPOINTED
Mak Jawadekar seat on NANOVIRICIDES, INC., effective 2025-10-08.
EffectiveEffective Oct 8, 2025E3
Monitoring
ContinuousWhat the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.
- IdentityunclaimedPublished
- Evidencesource_reportedPublished
- Evaluationnot_evaluatedPublished
- MonitoringNot yet published for this record.Not published
- AuthorityNot yet published for this record.Not published
- FreshnesscurrentPublished
Leadership
Evidence| Role | Person | Since | Status | Claim |
|---|---|---|---|---|
| Vice President of Research and Development | Jayant Tatake | Sep 2025 | current | Source reportedE4 |
| President and Chief Executive Officer | Anil Diwan | Not captured | unknown | Source reportedE2 |
| Chief Financial Officer | Meeta Vyas | Not captured | unknown | Source reportedE2 |
Board of directors
Evidence5 directors published. Independence determinations are not published for every director.
| Director | Status | Since | Committees | Claim |
|---|---|---|---|---|
| Brian Zucker | Independence not published | 2020 | Audit Committee, chairCompensation CommitteeNominating and Corporate Governance Committee | Source reportedE3 |
| Mak Jawadekar | Independence not published | 2025 | Compensation CommitteeNominating and Corporate Governance Committee, chair | Source reportedE3 |
| Makarand Jawadekar | Independence not published | 2025 | None published | Source reportedE3 |
| Theodore Edward | Independence not published | 2020 | None published | Source reportedE3 |
| Todd Rokita | Independence not published | 2025 | Audit CommitteeCompensation Committee, chairNominating and Corporate Governance Committee | Source reportedE3 |
| Anil Diwan | Not independentChair | Not published | Chairman of the Board of Directors | Source reportedE2 |
| Meeta Vyas | Not independent | Not published | None published | Source reportedE2 |
Committees and risk ownership
Evidence| Committee | Chair | Members | Risks assigned |
|---|---|---|---|
| Audit Committee | Brian Zucker | Brian Zucker, Todd Rokita | Not described in the published record |
| Chairman of the Board of Directors | Not published | Anil Diwan | Not described in the published record |
| Compensation Committee | Todd Rokita | Todd Rokita, Brian Zucker, Mak Jawadekar | Not described in the published record |
| Nominating and Corporate Governance Committee | Mak Jawadekar | Mak Jawadekar, Brian Zucker, Todd Rokita | Not described in the published record |
Committee RecordAudit Committee: Chair Brian Zucker; Members Brian Zucker (Chair); Todd Rokita
Committee AppointmentBrian Zucker: chair, Audit Committee
Committee AppointmentTodd Rokita: member, Audit Committee
Committee RecordCompensation Committee: Chair Todd Rokita; Members Todd Rokita (Chair); Brian Zucker; Mak Jawadekar
Committee AppointmentTodd Rokita: chair, Compensation Committee
Committee AppointmentBrian Zucker: member, Compensation Committee
Committee AppointmentMak Jawadekar: member, Compensation Committee
Committee RecordNominating and Corporate Governance Committee: Chair Mak Jawadekar; Members Mak Jawadekar (Chair); Brian Zucker; Todd Rokita
Committee AppointmentMak Jawadekar: chair, Nominating and Corporate Governance Committee
Committee AppointmentBrian Zucker: member, Nominating and Corporate Governance Committee
Committee AppointmentTodd Rokita: member, Nominating and Corporate Governance Committee
Control and voting power
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Authority to act
Evidence and agent registryWho can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.
Principal executive officerAnil Diwan, President and Chief Executive Officer
Who can authorize an agentNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
AI agents registered by the companyNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
Delegations publishedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
Financials and market context
EvidenceSecurity ListingNNVC (NYSE)
Security ListingNNVC (NYSE AMERICAN)
Index membershipsNo current membership is published in Alpha's tracked index universe.This is not evidence that the company is absent from every market index.
None publishedAs of Oct 22, 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.
Governance and policies
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Risk, audit, and cyber
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
AI oversight and accountability
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Legal and regulatory
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Compensation
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Other published claims
EvidencePublished Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.
Legal NameNANOVIRICIDES, INC.
Entity StatusPublic listing published
Published FactUS
Not yet in this record
CoverageA gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.
- Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
- OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
- FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
- CompensationNot reviewed. Pay design shows how incentives are governed.
- GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
- Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
- AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
- LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
- RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
- CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
- AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
- Markets externalNot reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.
Linked people
Same claims as person records- Jayant TatakeVice President of Research and Developmentcompany:6b088d6e-a8aa-47cb-9be3-eb19915ed477:leadership_role:13
- Anil DiwanPresident and Chief Executive Officer; President, Chairman of the Board of Directorscompany:6b088d6e-a8aa-47cb-9be3-eb19915ed477:leadership_role:12, company:6b088d6e-a8aa-47cb-9be3-eb19915ed477:leadership_role:5
- Meeta VyasChief Financial Officer; Director and Chief Financial Officercompany:6b088d6e-a8aa-47cb-9be3-eb19915ed477:leadership_role:14, company:6b088d6e-a8aa-47cb-9be3-eb19915ed477:leadership_role:9
- Brian ZuckerDirectorcompany:6b088d6e-a8aa-47cb-9be3-eb19915ed477:leadership_role:6
- Mak JawadekarDirectorcompany:6b088d6e-a8aa-47cb-9be3-eb19915ed477:leadership_role:7
- Makarand JawadekarDirectorcompany:6b088d6e-a8aa-47cb-9be3-eb19915ed477:leadership_role:8
- Theodore EdwardDirectorcompany:6b088d6e-a8aa-47cb-9be3-eb19915ed477:leadership_role:10
- Todd RokitaDirectorcompany:6b088d6e-a8aa-47cb-9be3-eb19915ed477:leadership_role:11
Subject and corrections
Public-role doctrineThis record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.
- Basis
- Published company record built from public sources
- Sources
- 5 evidence records cited. 0 with redistribution rights.
- Never published
- Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
- Record claimed
- No
- Open disputes
- 0
- Identity ownership
- unclaimed
Claiming not yet available
If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.
Evidence
Authority and rights- E1Alpha canonical company public projection. canonical identity. Retrieved Oct 22, 2026. Cited by 5 Claims.
- E2sec def 14a. Published Oct 8, 2025. Retrieved Sep 12, 2026. Cited by 4 Claims.
- E3sec proxy. Published Oct 8, 2025. Retrieved Sep 2, 2026. Cited by 5 Claims.
- E4sec filing. Published Sep 29, 2025. Retrieved May 16, 2026. Cited by 1 Claim.
- E5governance_people_committees. sec proxy. Cited by 11 Claims.
What changed in version public-1:ro-d751713988987e9331980363e24189ce
vpublic-1:ro-d751713988987e9331980363e24189ce published Oct 22, 2026- Mak Jawadekar seat on NANOVIRICIDES, INC., effective 2025-10-08.
- Makarand Jawadekar seat on NANOVIRICIDES, INC., effective 2025-10-08.
- Todd Rokita seat on NANOVIRICIDES, INC., effective 2025-10-08.
- Jayant Tatake executive of NANOVIRICIDES, INC., effective 2025-09-29.
- Brian Zucker seat on NANOVIRICIDES, INC., effective 2020-01-01.
- Theodore Edward seat on NANOVIRICIDES, INC., effective 2020-01-01.